Skip to content
10-Q

Quarterly Report

Oric Pharmaceuticals, Inc. ORIC

0000950170-25-107359

← back to feed
Filed
Aug 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 5, 2025 97.12M sh
Shares Diluted Q2 2025 · Jun 30, 2025 78.13M sh
Shares Diluted Q2 2025 · Jun 30, 2025 74.6M sh
Shares Diluted Q2 2025 · Jun 30, 2024 70.35M sh
Shares Diluted Q2 2025 · Jun 30, 2024 68.85M sh
Capex Q2 2025 · Jun 30, 2025 $450K
Capex Q2 2025 · Jun 30, 2024 $551K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$63.38M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$55.81M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $75.86M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $59.41M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $49.83M
Stockholders Equity Q2 2025 · Jun 30, 2025 $324M
Stockholders Equity Q2 2025 · Mar 31, 2025 $219.74M
Stockholders Equity Q2 2025 · Dec 31, 2024 $243.12M
Stockholders Equity Q2 2025 · Jun 30, 2024 $302.4M
Stockholders Equity Q2 2025 · Mar 31, 2024 $328.65M
Stockholders Equity Q2 2025 · Dec 31, 2023 $224.09M
Current Liabilities Q2 2025 · Jun 30, 2025 $18.05M
Current Liabilities Q2 2025 · Dec 31, 2024 $24.85M
Total Liabilities Q2 2025 · Jun 30, 2025 $22.86M
Total Liabilities Q2 2025 · Dec 31, 2024 $31.02M
Current Assets Q2 2025 · Jun 30, 2025 $291.12M
Current Assets Q2 2025 · Dec 31, 2024 $262.25M
Total Assets Q2 2025 · Jun 30, 2025 $346.86M
Total Assets Q2 2025 · Dec 31, 2024 $274.14M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.47
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.89
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.45
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.83
Eps Basic Q2 2025 · Jun 30, 2025 −$0.47
Eps Basic Q2 2025 · Jun 30, 2025 −$0.89
Eps Basic Q2 2025 · Jun 30, 2024 −$0.45
Eps Basic Q2 2025 · Jun 30, 2024 −$0.83
Sga Expense Q2 2025 · Jun 30, 2025 $8.52M
Sga Expense Q2 2025 · Jun 30, 2025 $16.59M
Sga Expense Q2 2025 · Jun 30, 2024 $7.08M
Sga Expense Q2 2025 · Jun 30, 2024 $14.11M
Net Income Q2 2025 · Jun 30, 2025 −$36.36M
Net Income Q2 2025 · Jun 30, 2025 −$66.38M
Net Income Q2 2025 · Jun 30, 2024 −$31.96M
Net Income Q2 2025 · Jun 30, 2024 −$56.97M
Operating Income Q2 2025 · Jun 30, 2025 −$39.06M
Operating Income Q2 2025 · Jun 30, 2025 −$71.78M
Operating Income Q2 2025 · Jun 30, 2024 −$36.02M
Operating Income Q2 2025 · Jun 30, 2024 −$65.01M